Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4923-4929

  Takagi, Masatoshi ^a   Delia, Domenico ^b   Chessa, Luciana ^c   Iwata, Satoshi ^a   Shigeta, Teruko ^a,d   Kanke, Yusuke ^d   Goi, Kumiko ^a,g   Asada, Minoru ^a   Eguchi, Mariko ^e   Kodama, Chie ^f   Mizutani, Shuki ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f Veritas Corporation   (Japan)

^g UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; PROTEIN P53;

APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; CELL CYCLE; DNA DAMAGE; FAMILIAL CANCER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; X IRRADIATION;

EID: 15144347816     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Sedgewick, R. P., and Boder, E. Ataxia-Telangiectasia. Handbook of Clinical Neurology, Vol. 16, p. 347-423. New York: Elsevier, 1991.
2. Lavin, M. F., and Shiloh, Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol., 15: 177-202, 1997.
3. Savitsky, K., Bar, S. A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (Washington DC), 268: 1749-1753, 1995.
4. Savitsky, K., Sfez, S., Tagle, D. A., Ziv, Y., Sartiel, A., Collins, F. S., Shiloh, Y., and Rotman, G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet., 4: 2025-2032, 1995.
5. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
6. Canman, C. E., Wolff, A. C., Chen, C. Y., Fornace, A. J., and Kastan, M. B. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res., 54: 5054-5058, 1994.
7. Watters, D., Khanna, K. K., Beamish, H., Birrell, G., Spring, K., Kedar, P., Gatei, M., Stenzel, D., Hobson, K., Kozlov, S., Zhang, N., Farrell, A., Ramsay, J., Gatti, R., and Lavin, M. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene, 14: 1911-1921, 1997.
8. Westphal, C. H., Schmaltz, C., Rowan, S., Elson, A., Fisher, D. E., and Leder, P. Genetic interactions between ATM and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res., 57: 1664-1667, 1997.
9. Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow. C., Baltimore, D., Wynshaw, B. A., Kastan, M. B., and Wang, J. Y. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature (Lond.), 387: 516-519, 1997.
10. Shafman, T., Khanna, K. K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, M., Zhang, N., Watters, D., Egerton, M., Shiloh, Y., Kharbanda, S., Kufe, D., and Lavin, M. F. Interaction between ATM protein and c-Abl in response to DNA damage. Nature (Lond.), 387: 520-523, 1997.
11. Cheng, X., Cheong, N., Wang, Y., and Iliakis, G. Ionizing radiation-induced phosphorylation of RPA p34 is deficient in ataxia telangiectasia and reduced in aged normal fibroblasts. Radiother. Oncol., 39: 43-52, 1996.
12. Liu, V. F., and Weaver, D. T. The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia telangiectasia and normal human cells. Mol. Cell. Biol., 13: 7222-7231, 1993.
13. Flaggs, G., Plug, A. W., Dunks, K. M., Mundt, K. E., Ford, J. C., Quiggle, M. R. E., Taylor, E. M., Westphal, C. H., Ashley, T., Hoekstra, M. F., and Carr, A. M. ATM-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes. Curr. Biol., 7: 977-986, 1997.
14. Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., and Elledge, S. J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (Washington DC), 277: 1497-1501, 1997.
15. Walworth, N. C., and Bernards, R. rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science (Washington DC), 271: 353-356, 1996.
16. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.
17. Goi, K., Takagi, M., Iwata, S., Delia, D., Asada, M., Donghi, R., Tsunematsu, Y., Nakazawa, S., Yamamoto, H., Yokota, J., Tamura, K., Saeki, Y., Utsunomiya, J., Takahashi, T., Ueda, R., Ishioka, C., Eguchi, M., Kamata, N., and Mizutani, S. DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. Cancer Res., 57: 1895-1902, 1997.
18. Pelloquin, F., Lamelin, J. P., and Lenoir, G. M. Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A. In Vitro Cell Dev. Biol., 22: 689-694, 1986.
19. Prudente, S., Piane, M., Brusco, A., Saviozzi, S., Carbonara, A., and Chessa, L. Mutations of the ATM gene in Italy recovered through different methodological approaches. Bull. Cancer, in press, 1998.
20. Delia, D., Goi, K., Mizutani, S., Yamada, T., Iwata, S., Aiello, A., Fontanella, E., Morte, G. L., and Pierotti, M. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. Oncogene, 14: 2137-2147, 1997.
21. Gilad, S., Khosravi, R., Shkedy, D., Uziel, T., Ziv, Y., Savitsky, K., Rotman, G., Smith, S., Chessa, L., Jorgensen, T. J., Harnik, R., Frydman, M., Sanal, O., Portnoi, S., Goldwicz, Z., Jaspers, N. G., Gatti, R. A., Lenoir, G., Lavin, M. F., Tatsumi, K., Wegner, R. D., Shiloh, Y., and Bar-Shira, A. Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet., 5: 433-439, 1996.
22. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
23. Huo, Y. K., Wang, Z., Hong, J. H., Chessa, L., McBride, W. H., Perlman, S. L., and Gatti, R. A. Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res., 54: 2544-2547, 1994.
24. Lakin, N. D., Weber, P., Stankovic, T., Rottinghaus, S. T., Taylor, A. M., and Jackson, S. P. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene, 13: 2707-2716, 1996.
25. Beamish, H., Williams, R., Chen, P., and Lavin, M. F. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem., 271: 20486-20493, 1996.
26. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., and Wynshaw, B. A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell, 86: 159-171, 1996.
27. Westphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E., and Leder, P. ATM and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat. Genet., 16: 397-401, 1997.
28. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (Lond.), 391: 43-50, 1998.
29. Taylor, A. M., Harnden, D. G., Arlett, C. F., Harcourt, S. A., Lehmann, A. R., Stevens, S., and Bridges, B. A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature (Lond.), 258: 427-429, 1975.
30. McKinnon, P. J. Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect. Hum. Genet., 75: 197-208, 1987.
31. Cole, J., Arlett, C. F., Green, M. H., Harcourt, S. A., Priestley, A., Henderson, L., Cole, H., James, S. E., and Richmond, F. Comparative human cellular radiosensitivity. II. The survival following gamma-irradiation of unstimulated (G0) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes. Int. J. Radiat. Biol., 54: 929-943, 1988.
32. Duchaud, E., Ridet, A., Stoppa, L. D., Janin, N., Moustacchi, E., and Rosselli, F. Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. Cancer Res., 56: 1400-1404, 1996.
33. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
34. Rotman, G., and Shiloh, Y. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bioessays, 19: 911-917, 1997.
35. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G., and Wiman, K. G. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA, 90: 5455-5459, 1993.
36. Zhang, Q., Gutsch, D., and Kenney, S. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol., 14: 1929-1938, 1994.
37. Allday, M. J., Sinclair, A., Parker, G., Crawford, D. H., and Farrell, P. J. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J., 14: 1382-1391, 1995.
38. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
39. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. A p53-dependent mouse spindle checkpoint. Science (Washington DC), 267: 1353-1356, 1995.
40. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
41. Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., and Kufe, D. W. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (Lond.), 376: 785-788, 1995.
42. Shafman, T. D., Saleem, A., Kyriakis, J., Weichselbaum, R., Kharbanda, S., and Kufe, D. W. Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Res., 55: 3242-3245, 1995.
43. Anderson, P. Kinase cascades regulating entry into apoptosis. Microbiol. Mol. Biol. Rev., 61: 33-46, 1997.
44. Chu, Z. L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., and Ballard, D. W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis C-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA, 94: 10057-10062, 1997.
45. Arsura, M., FitzGerald, M. J., Fausto, N., and Sonenshein, G. E. Nuclear factor-κB/Rel blocks transforming growth factor β1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ., 8: 1049-1059, 1997.
46. Shao, R., Karunagaran, D., Zhou, B. P., Li, K., Lo, S. S., Deng, J., Chiao, P., and Hung, M. C. Inhibition of nuclear factor-κB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J. Biol. Chem., 272: 32739-32742, 1997.
47. Jung, M., Zhang, Y., Lee, S., and Dritschilo, A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκB-α. Science (Washington DC), 268: 1619-1621, 1995.
48. Wang, L., Cui, Y., Lord, B. I., Roberts, S. A., Potten, C. S., Hendry, J. H., and Scott, D. Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice. Radiat. Res., 146: 259-266, 1996.
49. Hendry, J. H., and West, C. M. Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response. Int. J. Radiat. Biol., 71: 709-719, 1997.
50. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependenl and independent pathways. Nature (Lond.), 362: 849-852, 1993.
51. Khanna, K. K., Yan, J., Watters, D., Hobson, K., Beamish, H., Spring, K., Shiloh, Y., Gatti, R. A., and Lavin, M. F. Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells. J. Biol. Chem., 272: 9489-9495, 1997.
52. Barlow, C., Brown, K. D., Deng, C. X., Tagle, D. A., and Wynshaw-Boris, A. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat. Genet., 17: 453-456, 1997.